These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22038288)

  • 1. Invertebrate models of lysosomal storage disease: what have we learned so far?
    Hindle S; Hebbar S; Sweeney ST
    Invert Neurosci; 2011 Dec; 11(2):59-71. PubMed ID: 22038288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans as a model for lysosomal storage disorders.
    de Voer G; Peters D; Taschner PE
    Biochim Biophys Acta; 2008; 1782(7-8):433-46. PubMed ID: 18501720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones.
    Wei H; Kim SJ; Zhang Z; Tsai PC; Wisniewski KE; Mukherjee AB
    Hum Mol Genet; 2008 Feb; 17(4):469-77. PubMed ID: 17989065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and uncommon pathogenic cascades in lysosomal storage diseases.
    Vitner EB; Platt FM; Futerman AH
    J Biol Chem; 2010 Jul; 285(27):20423-7. PubMed ID: 20430897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis.
    Liu B; Du H; Rutkowski R; Gartner A; Wang X
    Science; 2012 Jul; 337(6092):351-4. PubMed ID: 22822152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VAMP associated proteins are required for autophagic and lysosomal degradation by promoting a PtdIns4P-mediated endosomal pathway.
    Mao D; Lin G; Tepe B; Zuo Z; Tan KL; Senturk M; Zhang S; Arenkiel BR; Sardiello M; Bellen HJ
    Autophagy; 2019 Jul; 15(7):1214-1233. PubMed ID: 30741620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.
    Li W; Cologna SM
    Mol Omics; 2022 May; 18(4):256-278. PubMed ID: 35343995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolic perturbation is an early-onset phenotype in adult
    Hebbar S; Khandelwal A; Jayashree R; Hindle SJ; Chiang YN; Yew JY; Sweeney ST; Schwudke D
    Mol Biol Cell; 2017 Dec; 28(26):3728-3740. PubMed ID: 29046397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases.
    Liu EA; Lieberman AP
    Neurosci Lett; 2019 Apr; 697():10-16. PubMed ID: 29704574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESCRT-Dependent Cell Death in a Caenorhabditis elegans Model of the Lysosomal Storage Disorder Mucolipidosis Type IV.
    Huynh JM; Dang H; Munoz-Tucker IA; O'Ketch M; Liu IT; Perno S; Bhuyan N; Crain A; Borbon I; Fares H
    Genetics; 2016 Feb; 202(2):619-38. PubMed ID: 26596346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Caenorhabditis elegans GARP complex contains the conserved Vps51 subunit and is required to maintain lysosomal morphology.
    Luo L; Hannemann M; Koenig S; Hegermann J; Ailion M; Cho MK; Sasidharan N; Zweckstetter M; Rensing SA; Eimer S
    Mol Biol Cell; 2011 Jul; 22(14):2564-78. PubMed ID: 21613545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from p53 in non-mammalian models.
    Lu WJ; Abrams JM
    Cell Death Differ; 2006 Jun; 13(6):909-12. PubMed ID: 16557266
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of induced pluripotent stem cells in lysosomal storage diseases.
    Kido J; Nakamura K; Era T
    Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.
    Marques ARA; Saftig P
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30651381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SnapShot: Lysosomal Storage Diseases.
    Martina JA; Raben N; Puertollano R
    Cell; 2020 Feb; 180(3):602-602.e1. PubMed ID: 32032518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lysosomal membrane protein SCAV-3 maintains lysosome integrity and adult longevity.
    Li Y; Chen B; Zou W; Wang X; Wu Y; Zhao D; Sun Y; Liu Y; Chen L; Miao L; Yang C; Wang X
    J Cell Biol; 2016 Oct; 215(2):167-185. PubMed ID: 27810910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.
    Sabitha KR; Chandran D; Shetty AK; Upadhya D
    Stem Cells Dev; 2022 May; 31(9-10):221-238. PubMed ID: 35316126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A saposin deficiency model in Drosophila: Lysosomal storage, progressive neurodegeneration and sensory physiological decline.
    Hindle SJ; Hebbar S; Schwudke D; Elliott CJH; Sweeney ST
    Neurobiol Dis; 2017 Feb; 98():77-87. PubMed ID: 27913291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.